« Back

Fourth Quarter Results for Fiscal 2025

Nov 11, 2025

Fiscal 2025 Revenue of $4.53 Billion, down 9.4% YoY as Reported and up 3.1% YoYin Pro Forma(1) Constant Currency(2)

Successfully Achieved Accelerated Profitability Improvement Targets

Strong Sales Momentum & 12-Month Backlog of $4.19 Billion, up 3.2% YoY

Initiates Fiscal 2026 Outlook:

Expects Fiscal 2026 Revenue Outlook of 1.7%-5.7% YoY as Reported and 1.0%-5.0% YoY in Constant Currency(2)

Increasing GenAI Investment to Unlock & Accelerate New Growth Opportunities

Board Approves 8% Increase of Quarterly Cash Dividend(4)

Full Year Fiscal 2025 Highlights

(All comparisons are against the prior year)

  • Revenue of $4,533 million, down 9.4% as reported due to the phase out of certain business activities, and up 3.1% in pro forma(1) constant currency(2)
  • Record managed services revenue of $2,996 million, equivalent to approximately 66% of total revenue
  • GAAP diluted EPS of $5.05, up 18.8% including a restructuring charge of 65 cents per share, without which GAAP diluted EPS would have been above the guidance range of 31.5%-33.5%
  • Non-GAAP diluted EPS of $6.99, up 8.5% and at the midpoint of the 8.0%-9.0% guidance range
  • Free cash flow(5) of $645 million, comprised of cash flow from operations of $749 million, less $104 million in net capital expenditures and other; excluding $90 million of restructuring payments which were not included in the full year free cash flow(5) guidance of $710 million to $730 million, free cash flow would have been $735 million
  • Repurchased $551 million of ordinary shares during the fiscal year
  • Twelve-month backlog of $4.19 billion up 3.2% as compared to last year's fourth fiscal quarter, and up approximately $40 million sequentially

Fourth Quarter Fiscal 2025 Highlights

(All comparisons are against the prior year)

  • Revenue of $1,150 million, down 9.0% as reported due to the phase out of certain business activities, and up 2.8% in pro forma(1) constant currency(2); revenue was above the midpoint of the $1,125-$1,165 million guidance range with no impact from foreign currency movements compared to our guidance assumptions
  • Managed services revenue of $748 million, equivalent to approximately 65% of total revenue and up 3.7% as compared to last year's fourth quarter
  • GAAP diluted EPS of $0.88, including a restructuring charge of 60 cents per share, without which GAAP diluted EPS would have been at the high-end of the $1.41-$1.49 guidance range
  • Non-GAAP diluted EPS of $1.83, slightly above the midpoint of the guidance range of $1.79-$1.85
  • GAAP operating income of $133 million; including a restructuring charge of $74 million; GAAP operating margin of 11.5%, up 260 basis points as compared to last year's fourth fiscal quarter, reflecting the phase out of certain non-core business activities, and a continued focus on operational excellence; GAAP operating margin was down 620 basis points sequentially,
  • Non-GAAP operating income of $248 million; non-GAAP operating margin of 21.6%, up 290 basis points as compared to last year's fourth fiscal quarter, reflecting the phase out of certain non-core business activities and a continued focus on operational excellence, and up 20 basis points sequentially
  • The Board of Directors (the "Board") approved an 8% increase in the Company's quarterly cash dividend payment from $0.527 per share to $0.569 per share, anticipated to be first paid in April 2026, subject to shareholder approval at the January 2026 annual meeting

(1) For comparison purposes, pro forma adjusts fourth quarter fiscal year 2024 revenue by approximately $150 million and the full fiscal 2024 revenue by approximately $600 million to reflect the end of certain low margin, non-core business activities; these activities substantially already ceased in the first quarter fiscal 2025 and are not included in the full year fiscal 2025 revenue outlook
(2) Revenue on a constant currency basis assumes exchange rates in the current period were unchanged from the prior period
(3) Expected total shareholder return assumes midpoint of fiscal year 2026 non-GAAP EPS growth outlook, plus dividend yield
(4) Subject to shareholder approval at January 2026 annual meeting
(5) Please refer to the Selected Financial Metrics tables below (figures may not sum because of rounding)

JERSEY CITY, NJ / ACCESS Newswire / November 11, 2025 / Amdocs Limited (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today reported operating results for the three months ended September 30, 2025.

"Fiscal 2025 was another important year as we delivered financial results consistent with our expectations while serving our global telecommunications customers with cutting-edge cloud, digital and AI-driven solutions designed to meet their strategic imperatives. Cloud-related activities delivered double-digit growth, reaching over 30% of total revenue, and we achieved significantly better profitability while maintaining our commitment to R&D. The year finished with very strong sales momentum. We secured Google Cloud migration awards at TELUS in Canada and Lumen Technologies in US and signed a digital transformation and IT operations agreement with Fidium, a new fiber customer in the US. Our international footprint expanded with modernization awards at British Telecom, or BT-EE in the UK, Altice SFR in France, Telia in Finland, PLDT in Philippines and Claro Brazil. Additionally, Telefónica Germany chose Amdocs to implement new GenAI use cases using the amAIz Sales Agent. This latest win extends our momentum following recent GenAI-related deals with Altice Optimum, e& UAE, and Consumer Cellular, and further demonstrates Amdocs' pivotal role in accelerating generative AI adoption in the telecom industry," said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.

"Profitability improved significantly in fiscal 2025, reflecting the phase-out of certain low-margin, non-core business activities a year ago, and internal efficiency gains driven by automation, AI and a focus on operational excellence. Managed services as a share of overall revenue reached a record high 66% this year, further strengthening our business resilience as we maintained high renewal rates and expanded our customer activities under long-term agreements. Notably, Amdocs announced today a multi-year strategic expansion of our long-standing managed services engagement with PLDT. This landmark agreement will focus on modernizing PLDT's IT operations and streamlining business processes through AI and generative AI capabilities to empower next-generation customer experiences," said Tamar Rapaport-Dagim, chief financial officer & chief operating officer of Amdocs Management Limited.

Sheffer concluded, "With our unique tech-led and outcomes-based accountability model, Amdocs is strongly positioned to monetize a rich pipeline of opportunities across cloud, digital, network, and generative AI. That said, we are closely watching for any impacts of the uncertain global macroeconomic environment on us and our customers' demand and spending behavior. As generative AI technology matures, we believe there is now the potential to unlock even greater opportunities to enhance telco customer experience, agility, and efficiency. To fully capture this potential, we are accelerating our generative AI investments to open new pathways for future growth across our entire customer base. Overall, we expect revenue growth in the range of 1.7% to 5.7% as reported and 1.0% to 5.0% in constant currency(2) in fiscal year 2026, positioning us to deliver high-single digit expected total shareholder returns(3) as we balance our strategic long-term investments with the benefits of ongoing cost and efficiency gains across the business."

Revenue

(All comparisons are against the prior year period)

 
 In millions 
 
 Three months ended  Twelve months ended 
 
 September 30, 2025  September 30, 2025 
 
 Actual  Previous
Guidance
  Actual  Previous
Guidance
 
Revenue
 $1,150  $1,125-$1,165  $4,533   - 
Revenue Growth, as reported
  (9.0)%  -   (9.4)%  (10.0)%-(9.0)% 
Revenue Growth, Pro-forma(1) constant currency(2)
  2.8%  -   3.1%  2.4%-3.4% 
  • Revenue for the fourth fiscal quarter of 2025 was above the midpoint of Amdocs' guidance
  • Revenue for the fourth fiscal quarter includes a positive impact from foreign currency movements of approximately $5 million relative to the fourth quarter of fiscal 2024 and a positive impact from foreign currency movements of approximately $3 million relative to the third quarter of fiscal 2025
  • Revenue for the full year fiscal 2025 includes an unfavorable impact from foreign currency movements of approximately 0.2% year-over-year

Net Income and Earnings Per Share

`
 In thousands, expect per share data 
 
 Three months ended  Twelve months ended 
 
 September 30,  September 30, 
 
 2025  2024  2025  2024 
GAAP Measures
            
Net Income
 $97,114  $87,176  $567,769  $496,321 
Net Income attributable to Amdocs Limited
 $96,327  $86,441  $564,704  $493,197 
Diluted earnings per share
 $0.88  $0.76  $5.05  $4.25 
 
                
Non-GAAP Measures
                
Non-GAAP Net Income
 $202,203  $195,668  $784,267  $750,928 
Non-GAAP Net Income attributable to Amdocs Limited
 $201,416  $194,933  $781,202  $747,804 
Non-GAAP Diluted earnings per share
 $1.83  $1.70  $6.99  $6.44 
  • Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition related liabilities measured at fair value, equity-based compensation expenses, restructuring charges, and other, net of related tax effects. For further details of the reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.

Capital Allocation

  • Quarterly Cash Dividend Program: On November 11, 2025, the Board approved the Company's next quarterly cash dividend payment of $0.527 per share, and set December 31, 2025 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on January 30, 2026
  • The Board also approved an 8% increase in the Company's quarterly cash dividend payment to $0.569 per share, which is anticipated to be first paid in April 2026, provided that the increase is approved by shareholders at the January 2026 annual general meeting of shareholders
  • Share Repurchase Activity: Repurchased $136 million of ordinary shares during the fourth quarter of fiscal 2025

Twelve-month Backlog

Twelve-month backlog was $4.19 billion at the end of the fourth quarter of fiscal 2025, up approximately 3.2% as compared to last year's fourth fiscal quarter. Twelve-month backlog includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities.

First Quarter Fiscal 2026 Outlook

 
 In millions, except per share data 
 
  Q1 - 2026 
Revenue
 $1,135-$1,175 
GAAP Diluted earnings per share
 $1.36-$1.44 
Non-GAAP Diluted earnings per share
 $1.73-$1.79 
  • First quarter revenue guidance assumes a negative $1 million sequential impact from foreign currency fluctuations as compared to the fourth quarter of fiscal 2025
  • First quarter non-GAAP diluted EPS guidance excludes primarily equity-based compensation expense of approximately $0.21-$0.23 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.11 per share, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effects
  • GAAP diluted EPS guidance does not include the impact of future restructuring charges

Full Year Fiscal 2026 Outlook

 
 FY 2026, year-over-year growth 
 
 Guidance 
Revenue growth, as reported
  1.7%-5.7% 
Revenue growth, constant currency(2)
  1.0%-5.0% 
GAAP diluted EPS growth
  13.5%-20.5% 
Non-GAAP diluted EPS growth
  4.0%-8.0% 
     
 
 FY 2026, in millions 
 
 Guidance 
Free cash flow(5)
 $710-$730 
  • Full year fiscal 2026 revenue guidance incorporates an expected positive impact from foreign currency fluctuations of approximately 0.7% year-over-year and includes some inorganic contribution
  • Non-GAAP diluted earnings per share growth excludes primarily equity-based compensation expense of approximately $0.90-$0.98 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.41 per share, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effects
  • GAAP diluted EPS guidance does not include the impact of future restructuring charges
  • Non-GAAP operating margin is anticipated to be within a range of 21.3% to 21.9% for the full year fiscal 2026
  • Non-GAAP operating margin is comprised of GAAP operating margin, excluding amortization of purchased intangible assets and other, equity-based compensation expense, restructuring charges, and changes in certain acquisitions related liabilities measured at fair value
  • Non-GAAP effective tax rate is anticipated to be within a range of 16% to 19% for the full year fiscal 2026
  • Full year fiscal 2026 free cash flow(5) of $710 million to $730 million; free cash flow(5) is comprised of cash flow from operations, less net capital expenditures, and excludes payments related to restructuring charges

The forward-looking statements regarding our first fiscal quarter 2026 and full year fiscal 2026 guidance take into consideration the Company's current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, we note that market dynamics continue to shift rapidly and we cannot predict all possible outcomes, including those resulting from certain geopolitical events, the current inflationary environment, changes to trade policies including tariffs and trade restrictions and the resulting impact on economic activities (as our outlook assumes current economic conditions do not deteriorate significantly due to trade policy or other macro factors), global or regional events, and the prevailing level of macro-economic, business and operational uncertainty, which have created, and continue to create, a significant amount of uncertainty, or from current and potential customer consolidation or their other strategic corporate activities.

Conference Call and Earnings Webcast Presentation Details

Amdocs will host a conference call and earnings webcast presentation on November 11, 2025 at 5:00 p.m. Eastern Time to discuss the Company's fourth quarter of fiscal 2025 results. To participate in the call, please register here to receive the dial-in numbers and unique access PIN. The conference call and webcast will also be carried live on the Internet and may be accessed via the Amdocs website at https://investors.amdocs.com. Presentation slides will be available shortly before the webcast.

Non-GAAP Financial Measures 
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow(5), revenue on a constant currency(2) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth. These other non-GAAP measures exclude the following items:

  • amortization of purchased intangible assets and other acquisition-related costs;
  • changes in certain acquisition-related liabilities measured at fair value;
  • restructuring and unusual charges or benefits;
  • equity-based compensation expense;
  • other; and
  • tax effects related to the above.

Free cash flow(5) equals cash generated by operating activities less net capital expenditures. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow(5), revenue on a constant currency(2) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, restructuring and unusual charges or benefits, equity-based compensation expense, other and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

Supporting Resources

About Amdocs

Amdocs empowers the world's leading communications and media companies to accelerate innovation and deliver exceptional customer experiences at scale. Our comprehensive portfolio of software products and services enable service providers to harness the transformative power of artificial intelligence, driving digital modernization, cloud adoption, intelligent network automation, and new revenue opportunities. With our talented people across the globe, we partner with our customers to turn advanced technology into measurable business outcomes, enriching lives and advancing a more connected society. Together, we help those who shape the future to make it amazing. Listed on the NASDAQ Global Select Market, Amdocs reported revenue of $4.53 billion in fiscal 2025.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events or pandemics, changes to trade policies including tariffs and trade restrictions, as well as the current inflationary environment, and the effects of these conditions on the Company's customers' businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company's customers. Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company's offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2024, filed on December 17, 2024, and our Form 6-K furnished for the first quarter of fiscal 2025 on February 18, 2025, for the second quarter of fiscal 2025 on May 19, 2025, and for the third quarter of fiscal 2025 on August 18, 2025.

Contact
Matthew Smith
Head of Investor Relations
Amdocs
314-212-8328
E-mail: dox_info@amdocs.com

AMDOCS LIMITED
Consolidated Statements of Income 
(In thousands, except per share data)

 
 Three months ended 
September 30,
  Fiscal year ended 
September 30,
 
 
 2025 (a)  2024  2025 (a)  2024 
Revenue
 $1,150,218  $1,263,882  $4,532,913  $5,004,989 
Operating expenses:
                
Cost of revenue
  719,878   824,888   2,811,333   3,249,598 
Research and development
  87,865   90,069   340,845   360,798 
Selling, general and administrative
  121,807   138,705   506,108   572,845 
Amortization of purchased intangible assets and other
  14,287   14,333   62,424   62,052 
Restructuring charges
  73,756   83,213   80,539   131,088 
 
  1,017,593   1,151,208   3,801,249   4,376,381 
Operating income
  132,625   112,674   731,664   628,608 
Interest and other expense, net
  (11,843)  (9,237)  (38,422)  (37,537)
Income before income taxes
  120,782   103,437   693,242   591,071 
Income taxes
  23,668   16,261   125,473   94,750 
Net income
 $97,114  $87,176  $567,769  $496,321 
Net income attributable to noncontrolling interests
  787   735   3,065   3,124 
Net income attributable to Amdocs Limited
 $96,327  $86,441  $564,704  $493,197 
Basic earnings per share attributable to Amdocs Limited
 $0.88  $0.76  $5.08  $4.27 
Diluted earnings per share attributable to Amdocs Limited
 $0.88  $0.76  $5.05  $4.25 
Basic weighted average number of shares outstanding
  109,279   113,745   111,147   115,489 
Diluted weighted average number of shares outstanding
  109,853   114,378   111,746   116,145 
Cash dividends declared per share
 $0.527  $0.479  $2.060  $1.872 

AMDOCS LIMITED
Selected Financial Metrics
(In thousands, except per share data)

 
 Three months ended
September 30,
  Fiscal year ended 
September 30,
 
 
 2025(a)  2024  2025(a)  2024 
             
Revenue
 $1,150,218  $1,263,882  $4,532,913  $5,004,989 
Non-GAAP operating income
  248,118   236,223   968,330   923,288 
Non-GAAP net income
  202,203   195,668   784,267   750,928 
Non-GAAP net income attributable to Amdocs Limited
  201,416   194,933   781,202   747,804 
Non-GAAP diluted earnings per share
 $1.83  $1.70  $6.99  $6.44 
Diluted weighted average number of shares outstanding
  109,853   114,378   111,746   116,145 

Free Cash Flows
(In thousands)

 
 Three months ended
September 30,
  Fiscal year ended 
September 30,
 
 
 2025  2024  2025  2024 
             
Net Cash Provided by Operating Activities
 $229,840  $217,922  $749,096  $724,428 
Purchases of property and equipment, net (b)
  (31,212)  (25,812)  (103,952)  (105,495)
Free Cash Flow
 $198,628  $192,110  $645,144  $618,933 

(a) During the three months ended December 31, 2024, we phased out several low-margin, non-core business activities, which were included in the prior periods numbers.
(b) The amounts under "Purchase of property and equipment, net", include immaterial proceeds from sale of property and equipment for all periods presented.

AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(In thousands)

  Three Months Ended September 30, 2025(a)   
 
 GAAP Amortization of purchased intangible assets and other Equity based compensation expense Changes in certain acquisitions related liabilities measured at fair value Restructuring charges Other Tax 
effect
 Non-GAAP 
Operating expenses:
                 
Cost of revenue
 $719,878 $- $(13,062)$(360)$- $- $- $706,456 
Research and development
  87,865     (2,600)             85,265 
Selling, general and administrative
  121,807     (11,068) (360)          110,379 
Amortization of purchased intangible assets and other
  14,287  (14,287)                - 
Restructuring charges
  73,756           (73,756)       - 
Total operating expenses
  1,017,593  (14,287) (26,730) (720) (73,756) -  -  902,100 
Operating income
  132,625  14,287  26,730  720  73,756        248,118 
Interest and other expense, net
  (11,843)             1,545     (10,298)
Income taxes
  23,668                 11,949  35,617 
Net income
  97,114  14,287  26,730  720  73,756  1,545  (11,949) 202,203 
Net income attributable to noncontrolling interests
  787                    787 
Net income attributable to Amdocs Limited
 $96,327 $14,287 $26,730 $720 $73,756 $1,545 $(11,949)$201,416 
 
 Three Months Ended September 30, 2024 
 
 GAAP Amortization of purchased intangible assets and other Equity based compensation expense Restructuring charges Other Tax 
effect
 Non-GAAP 
Operating expenses:
               
Cost of revenue
 $824,888 $- $(13,283)$- $- $- $811,605 
Research and development
  90,069     (2,355)          87,714 
Selling, general and administrative
  138,705     (10,365)          128,340 
Amortization of purchased intangible assets and other
  14,333  (14,333)             - 
Restructuring charges
  83,213        (83,213)       - 
Total operating expenses
  1,151,208  (14,333) (26,003) (83,213)       1,027,659 
Operating income
  112,674  14,333  26,003  83,213        236,223 
Interest and other expense, net
  (9,237)          2,549     (6,688)
Income taxes
  16,261              17,606  33,867 
Net income
  87,176  14,333  26,003  83,213  2,549  (17,606) 195,668 
Net income attributable to noncontrolling interests
  735                 735 
Net income attributable to Amdocs Limited
 $86,441 $14,333 $26,003 $83,213 $2,549 $(17,606)$194,933 

AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(In thousands)

 
 Fiscal year ended September 30,2025(a) 
 
 GAAP Amortization of purchased intangible assets and other Equity based compensation expense Changes in certain acquisitions related liabilities measured at fair value Restructuring charges Other Tax 
effect
 Non-GAAP 
Operating expenses:
                 
Cost of revenue
 $2,811,333 $- $(51,320)$(1,081)$- $- $- $2,758,932 
Research and development
  340,845     (9,603)             331,242 
Selling, general and administrative
  506,108     (43,941) 12,242           474,409 
Amortization of purchased intangible assets and other
  62,424  (62,424)                - 
Restructuring charges
  80,539           (80,539)       - 
Total operating expenses
  3,801,249  (62,424) (104,864) 11,161  (80,539)       3,564,583 
Operating income
  731,664  62,424  104,864  (11,161) 80,539        968,330 
Interest and other expense, net
  (38,422)             7,524     (30,898)
Income taxes
  125,473                 27,692  153,165 
Net income
  567,769  62,424  104,864  (11,161) 80,539  7,524  (27,692) 784,267 
Net income attributable to noncontrolling interests
  3,065                    3,065 
Net income attributable to Amdocs Limited
 $564,704 $62,424 $104,864 $(11,161)$80,539 $7,524 $(27,692)$781,202 
 
 Fiscal year ended September 30,2024 
 
 GAAP Amortization of purchased intangible assets and other Equity based compensation expense Changes in certain acquisitions related liabilities measured at fair value Restructuring charges Other Tax 
effect
 Non-GAAP 
Operating expenses:
                 
Cost of revenue
 $3,249,598 $- $(53,409)$3,000 $- $- $- $3,199,189 
Research and development
  360,798     (8,644)             352,154 
Selling, general and administrative
  572,845     (42,487)             530,358 
Amortization of purchased intangible assets and other
  62,052  (62,052)                - 
Restructuring charges
  131,088           (131,088)       - 
Total operating expenses
  4,376,381  (62,052) (104,540) 3,000  (131,088)       4,081,701 
Operating income
  628,608  62,052  104,540  (3,000) 131,088        923,288 
Interest and other expense, net
  (37,537)             8,087     (29,450)
Income taxes
  94,750                 48,160  142,910 
Net income
  496,321  62,052  104,540  (3,000) 131,088  8,087  (48,160) 750,928 
Net income attributable to noncontrolling interests
  3,124                    3,124 
Net income attributable to Amdocs Limited
 $493,197 $62,052 $104,540 $(3,000)$131,088 $8,087 $(48,160)$747,804 

AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(In thousands)

  As of 
  September 30,
2025
  September 30,
2024
 
ASSETS
      
Current assets:
      
Cash and cash equivalents
 $324,999  $346,085 
Short-term interest-bearing investments
  -   168,242 
Accounts receivable, net, including unbilled
  935,751   1,028,357 
Prepaid expenses and other current assets
  331,387   228,498 
Total current assets
  1,592,137   1,771,182 
 
        
Property and equipment, net
  768,557   755,601 
Lease assets
  182,088   149,254 
Goodwill and other intangible assets, net
  3,046,962   3,005,637 
Other noncurrent assets
  660,086   704,468 
Total assets
 $6,249,830  $6,386,142 
 
        
LIABILITIES AND SHAREHOLDERS' EQUITY
        
 
        
Current liabilities
        
Accounts payable, accruals and other
 $1,201,206  $1,315,679 
Lease liabilities
  38,725   39,983 
Deferred revenue
  118,861   115,247 
Total current liabilities
  1,358,792   1,470,909 
Lease liabilities
  140,776   103,462 
Long-term debt, net of unamortized debt issuance costs
  646,901   646,291 
Other noncurrent liabilities
  632,681   666,303 
Total Amdocs Limited Shareholders' equity
  3,429,453   3,456,976 
Noncontrolling interests
  41,227   42,201 
Total equity
  3,470,680   3,499,177 
Total liabilities and equity
 $6,249,830  $6,386,142 

AMDOCS LIMITED
Consolidated Statements of Cash Flows
(In thousands)

 
 2025  2024 
Cash Flow from Operating Activities:
      
Net income
 $567,769  $496,321 
Reconciliation of net income to net cash provided by operating activities:
        
Depreciation, amortization and impairment
  195,435   195,234 
Amortization of debt issuance cost
  608   596 
Equity-based compensation expense
  104,864   104,540 
Deferred income taxes
  20,291   (45,673)
Loss from short-term interest-bearing investments
  3,487   5,576 
Net changes in operating assets and liabilities, net of amounts acquired:
        
Accounts receivable, net
  79,606   (104,413)
Prepaid expenses and other current assets
  (55,061)  (8,478)
Other noncurrent assets
  (15,445)  (2,250)
Lease assets and liabilities, net
  3,221   (6,485)
Accounts payable, accrued expenses and accrued personnel
  (77,041)  216,324 
Deferred revenue
  8,172   (60,332)
Income taxes payable, net
  (15,109)  (47,241)
Other noncurrent liabilities
  (71,701)  (19,291)
Net cash provided by operating activities
  749,096   724,428 
Cash Flow from Investing Activities:
        
Purchase of property and equipment, net(b)
  (103,952)  (105,495)
Proceeds from sale of short-term interest-bearing investments
  169,993   68,659 
Purchase of short-term interest-bearing investments
  -   (9,061)
Net cash paid for business and intangible assets acquisitions
  (86,317)  (86,824)
Net cash from equity investments and other
  18,215   5,315 
Net cash used in investing activities
  (2,061)  (127,406)
Cash Flow from Financing Activities:
        
Repurchase of shares
  (551,340)  (563,121)
Proceeds from employee stock option exercises
  21,294   26,949 
Payments of dividends
  (224,394)  (211,967)
Distribution to noncontrolling interests
  (4,039)  (4,096)
Payment of contingent consideration and deferred payment of business acquisitions
  (9,642)  (18,782)
Net cash used in financing activities
  (768,121)  (771,017)
Net decrease in cash and cash equivalents
  (21,086)  (173,995)
Cash and cash equivalents at beginning of year
  346,085   520,080 
Cash and cash equivalents at end of year
 $324,999  $346,085 

AMDOCS LIMITED
Supplementary Information
(In millions)

 
 Three months ended 
 
 September 30,  June 30,  March 31,  December 31,  September 30, 
 
 2025 (a)  2025 (a)  2025 (a)  2024 (a)  2024 
North America
 $762.4  $745.4  $738.3  $737.4  $835.8 
Europe
  179.8   189.4   180.7   155.2   184.1 
Rest of the World
  208.0   209.6   209.2   217.4   244.0 
Total Revenue
 $1,150.2  $1,144.4  $1,128.2  $1,110.1  $1,263.9 
    
 
 Three months ended 
 
 September 30,  June 30,  March 31,  December 31,  September 30, 
 
 2025  2025  2025  2024  2024 
Managed Services Revenue
 $748.3  $771.5  $747.1  $728.9  $721.4 
 
 As of 
 
 September 30,  June 30,  March 31,  December 31,  September 30, 
 
 2025  2025  2025  2024  2024(c) 
12-Month Backlog
 $4,190  $4,150  $4,170  $4,140  $4,060 

(c) Excluding the phase out of certain business activities in the fourth fiscal quarter of 2024 only.

SOURCE: Amdocs - IR